SOLIGENIX, INC. Operating Lease Right-of-Use Assets
SOLIGENIX, INC. (SNGX) had Operating Lease Right-of-Use Assets of $298.33 thousand as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-07
- 2026-06-30: Operating Lease, Right-of-Use Asset $298.33K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $326.94K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $354.96K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $382.42K.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2026-06-30 | $298.33K 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $326.94K 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $354.96K 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $382.42K 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $409.30K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $77.10K 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $108.96K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $140.15K 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $170.68K 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $200.57K 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $229.83K 10-K · filed 2025-03-21 | |
| 2023-09-30 | $258.49K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $286.56K 10-Q · filed 2023-08-21 | |
| 2023-03-31 | $314.05K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $340.99K 10-K · filed 2024-03-15 | |
| 2022-09-30 | $367.38K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $393.23K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $75.23K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $106.16K 10-K · filed 2024-03-15 | |
| 2021-09-30 | $136.32K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $165.75K 10-Q · filed 2021-08-13 | |
| 2020-12-31 | $222.44K 10-K · filed 2023-03-31 | |
| 2019-12-31 | $112.39K 10-K · filed 2022-03-29 | $112.39K 10-K · filed 2020-03-30 |
| 2019-09-30 | $144.31K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $175.45K 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $205.84K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $235.50K 10-K · filed 2020-03-30 | $235.49K 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |